Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

SCYNEXIS Stock Price, Quotes and Forecasts | NASDAQ:SCYX | Benzinga

Q: What sector and industry does SCYNEXIS (SCYX) operate in?

SCYNEXIS is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.

Explore SCYNEXIS stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for SCYX.

Open	-
Close	-
Volume / Avg.	0 / 224.26K
Day Range	- - -
52 Wk Range	0.82 - 3.07
Market Cap	$42.10M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	51
Short Interest	2.54%
Days to Cover	4.45

Recent News

Why Resources Connection Shares Are Trading Higher By Over 6%; Here Are 20 Stocks Moving Premarket

Shares of Resources Connection, Inc. (NASDAQ: RGP) rose sharply in pre-market trading following better-than-expected results for its second quarter.

Avi Kapoor

Gold Moves Lower; TransCode Therapeutics Shares Surge

U.S. stocks traded mixed toward the end of trading, with the Nasdaq Composite trading higher by around 30 points on Monday. The Dow traded down 0.07% to 33,939.93 while the NASDAQ rose 0.24% to 13,243.56. The S&P 500 also rose, gaining, 0.19% to 4,328.30.

Lisa Levin

Why Brainstorm Cell Therapeutics Shares Are Trading Lower By 33%? Here Are Other Stocks Moving In Monday's Mid-Day Session

Gainers TransCode Therapeutics, Inc. (NASDAQ: RNAZ) shares jumped 308% to $2.71 after the company announced pre-clinical gliblastoma results with its lead candidate, TTX-MC138.

Lisa Levin

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Rating and Forecast

4.0

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	-
Close	-
Volume / Avg.	0 / 224.26K
Day Range	- - -
52 Wk Range	0.82 - 3.07
Market Cap	$42.10M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	51
Short Interest	2.54%
Days to Cover	4.45

About Scynexis Inc

Sector

Health Care

Industry

Pharmaceuticals

SCYNEXIS Inc is a drug development company that focuses on the development and commercialization of ...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy SCYNEXIS (SCYX) stock?

You can purchase shares of SCYNEXIS (NASDAQ:SCYX) through any online brokerage.

View our list of the best stock brokerages

Who are SCYNEXIS (SCYX) competitors?

Other companies in SCYNEXIS’s space includes: Iterum Therapeutics (NASDAQ:ITRM), CalciMedica (NASDAQ:CALC), Rani Therapeutics Hldgs (NASDAQ:RANI), VYNE Therapeutics (NASDAQ:VYNE) and Cara Therapeutics (NASDAQ:CARA).

What is the forecast, or price target, for SCYNEXIS (SCYX) stock?

SCYNEXIS has a consensus price target of $10.00.

What is the current price for SCYNEXIS (SCYX)?

The stock price for SCYNEXIS (NASDAQ: SCYX) is $1.08 last updated March 17, 2025 at 7:29 PM EDT.

Does SCYNEXIS (SCYX) pay a dividend?

There are no upcoming dividends for SCYNEXIS.

When is SCYNEXIS (NASDAQ:SCYX) reporting earnings?

SCYNEXIS’s Q1 earnings are confirmed for Wednesday, May 7, 2025.

Is SCYNEXIS (SCYX) going to split?

There is no upcoming split for SCYNEXIS.

What sector and industry does SCYNEXIS (SCYX) operate in?

SCYNEXIS is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.

Comments

SCYNEXIS Stock Price, Quotes and Forecasts

SCYNEXIS (SCYX) Forecast